No Data
Citi Maintains Macrogenics(MGNX.US) With Buy Rating, Cuts Target Price to $14
Macrogenics Is Maintained at Buy by Citigroup
Express News | MacroGenics Inc : Citigroup Cuts Target Price to $14 From $16
MacroGenics, Inc. (NASDAQ:MGNX) Just Reported, And Analysts Assigned A US$7.50 Price Target
MacroGenics, Inc. (NASDAQ:MGNX) Just Reported And Analysts Have Been Cutting Their Estimates
Buy Rating Affirmed for MacroGenics: Potential Growth Amid Oncology Trials and Solid Financials